Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation

Overview of attention for article published in Annals of Hematology, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 15,339 followers.

Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple #myeloma cell proliferation: https://t.co/np2MlC95mu. https://t.co/d2SiAZSKeu

20 Nov 2018

Reply Repost Favourite

RT @ImmunePC_Papers: PC | Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell…

17 Nov 2018

Reply Repost Favourite

PC | Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation. https://t.co/dUBR11EEuY

17 Nov 2018

Reply Repost Favourite